Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Alexander v. Abbott Laboratories Inc
Case Number:
3:12-cv-00052
Court:
Nature of Suit:
Judge:
Firms
- Audet & Partners
- Bracewell LLP
- Burg Simpson
- Cates Mahoney
- Daniels & Tredennick
- Douglas & London
- Fibich Leebron
- Heninger Garrison
- Kirkland & Ellis
- Kralovec Jambois
- Nelson Mullins
- Schlichter Bogard
- Venable LLP
- Wheeler Trigg
- Williams Hart
- Winston & Strawn
- Zoll & Kranz
Companies
Sectors & Industries:
-
January 19, 2018
Abbott, Plaintiffs Seek Stay Of Depakote Suits, Pending Talks
Abbott Laboratories Inc. and AbbVie Inc., along with more than 200 plaintiffs, asked an Illinois federal judge Friday to pause dozens of cases over birth defects allegedly caused by a seizure medication, as the drugmakers participate in settlement negotiations.
-
October 10, 2017
Plaintiffs Can't Drop Cases Before Depakote Trial: Judge
An Illinois federal judge signaled frustration Tuesday with the plaintiffs in mass litigation against Abbott Laboratories over birth defects allegedly caused by the drug Depakote, suggesting they are trying to game the system and refusing to dismiss without prejudice several cases slated for trial in the next year.
-
September 28, 2017
Missing Doctor Doesn't Doom Abbott Depakote Case, For Now
An Illinois federal judge shot down Abbott Laboratories Inc.'s attempt to escape litigation over birth defects allegedly caused by its seizure drug Depakote, ruling Thursday that it's too early to throw the case away just because a key witness can't be deposed.
-
May 09, 2017
Ill. Mom Says Ind. Time Limits Don't Apply In Depakote Case
Plaintiffs suing Abbott Laboratories Inc. over birth defects allegedly caused by the seizure drug Depakote asked an Illinois federal judge on Tuesday to reverse a decision granting summary judgment, saying that Indiana's statute of repose does not apply in this case.
-
April 19, 2017
4 Consumers Drop Abbott Depakote Birth Defect Suits
Four women who say Abbott Laboratories Inc.'s seizure drug Depakote caused birth defects in themselves or their children on Tuesday asked an Illinois federal court to dismiss them from litigation against the drugmaker.
-
April 17, 2017
Abbott Says Consumers Are Twisting Law In Depakote Suits
Abbott Laboratories Inc. told the Illinois federal judge overseeing litigation over claims that its seizure drug Depakote causes birth defects, that consumers are mischaracterizing the term "labeling" as used in Michigan law in arguing that the term encompasses promotional and marketing materials.
-
April 12, 2017
Depakote Birth Defect Suits Lose Claims Over Repose Limit
An Illinois federal judge on Tuesday dismissed nine of the plaintiffs whose cases were consolidated into the litigation against Abbott Laboratories Inc. over birth defects allegedly caused by the seizure drug Depakote, saying the statute of repose expired on the at-issue claims.
-
April 10, 2017
Abbott Admitted To Depakote Mislabeling, Court Told
Plaintiffs in litigation against Abbott Laboratories Inc. over birth defects allegedly caused by Depakote urged an Illinois federal court Monday to reject the drugmaker's bid for a quick win, saying Abbott admitted it had mislabeled the seizure treatment.